Related Articles
Importance of driver gene mutation assessment and targeted therapy for patients with early‑stage non‑small cell lung cancer and non‑R0 resection
Quantitative promoter hypermethylation analysis of RASSF1A in lung cancer: Comparison with methylation-specific PCR technique and clinical significance
Hypermethylation of normal mucosa of esophagus‑specific 1 is associated with an unfavorable prognosis in patients with non‑small cell lung cancer
Methylation of the RASSF1A and RARβ genes as a candidate biomarker for lung cancer
CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer